Clinical Trials Logo

Filter by:
NCT ID: NCT05224388 Completed - COVID-19 Clinical Trials

Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.

Start date: January 1, 2020
Phase:
Study type: Observational

To see whether our increased dosing regimen of unfractionated heparin (UF) and low molecular weight heparin (LMWH) in COVID-19 patients was effective at preventing thrombo-embolic complications. We did regular anti-Xa tests to optimise the dose of our thromboprophylaxis. Furthermore, we want to examine the time it takes to reach adequate anti-Xa levels, to determine additional risk factors and do a subgroup analysis. Lastly, we will study if there are possible complications of our thromboprophylactic therapy.

NCT ID: NCT05224115 Completed - Huntington Disease Clinical Trials

Dosimetry of [11C]CHDI-180R and [11C]CHDI-626.

Start date: July 17, 2020
Phase:
Study type: Observational

A better understanding of the HD pathogenesis mechanisms may lead to a better understanding of disease pathology, progression and development of targeted therapies. [11C]CHDI-00485180-R and [11C]CHDI-00485626 are two novel mutant huntingtin aggregate binding PET radioligands which have already demonstrated sensitivity to mutant huntingtin load in animal models. In the current study, the biodistribution and dosimetry of both these ligands will be investigated in young healthy volunteers according to a standard approach, in 3 subjects (including both genders) per tracer.

NCT ID: NCT05217992 Completed - Hemophilia Clinical Trials

Are There Differences Between Carriers of Haemophilia A and B?

Start date: May 25, 2021
Phase:
Study type: Observational

This study aims to develop a systematic genetic screening strategy for (potential) female carriers of haemophilia by identifying as many female carriers as possible within the families of haemophilia patients regularly followed at Cliniques universitaires Saint-Luc (CUSL) and to search for differences between female carriers of haemophilia A (HA) and B (HB).

NCT ID: NCT05213377 Completed - Clinical trials for Hypothermia; Anesthesia

Preoperative Warming, Hypothermia and Functional Recovery in Total Hip Arthroplasty

Start date: January 5, 2022
Phase: N/A
Study type: Interventional

This prospective, randomized, single-center study compares intraoperative heat loss at the core temperature level in patients scheduled for direct anterior total hip arthroplasty under general anesthesia and who will or will not, according to randomization, receive one hour of pre-warming with a pulsed air thermal blanket prior to anesthesia induction.

NCT ID: NCT05206162 Completed - Clinical trials for Cortical Excitability

TMS-EEG as a Tool to Study the Neuromodulatory Effects of Theta Burst Stimulation

Start date: August 2, 2017
Phase: N/A
Study type: Interventional

To assess the effect of continuous (cTBS) and intermittent theta burst stimulation (iTBS) stimulation on motor cortex excitability using TMS-EEG. Based on prior literature, the investigators hypothesized that N100 amplitude would be differently modulated by these two modalities.

NCT ID: NCT05204810 Completed - Hemodialysis Clinical Trials

Optimisation of Anticoagulation in Patients on Nocturnal Hemodialysis

Start date: February 1, 2022
Phase: N/A
Study type: Interventional

To avoid clotting during extracorporeal treatment, an anticoagulant is added to the circuit, resulting in an increased risk for bleeding complications. In addition, there is evidence that a substantial number of fibers can become blocked before this is reflected in routinely observed parameters, or in termination of the dialysis session. In standard hemodialysis of 4 hours, the anticoagulant is administered at the beginning of dialysis. For nocturnal hemodialysis, there is no hard evidence whether anticoagulation should be administered only at the dialysis start or with an extra dosing halfway the dialysis session. The aim of this randomized cross-over study is to objectively quantify the number of patent fibers after nocturnal dialysis in two different settings: anticoagulation only at the dialysis start, and anticoagulation divided over two time points, i.e. dialysis start and halfway dialysis.

NCT ID: NCT05204316 Completed - Headache Disorders Clinical Trials

NLP Headache Speech (NLPH-SPEECH): a Cross-sectional Study on Natural Language Processing Analysing Spoken Monologues by Headache Patients

NLPH SPEECH
Start date: January 13, 2022
Phase: N/A
Study type: Interventional

The research collects spoken descriptions of headache disorders by participants with headache disorders. The speech recordings are analyzed by natural language processing (NLP) tools to analyse linguistic properties of the texts and to obtain insight into the potential of NLP machine learning models for the recognition of headache syndromes of the participants.

NCT ID: NCT05199987 Completed - Clinical trials for Severe Chronic Obstructive Pulmonary Disease

Breathing Control Exercises in Patients With Chronic Obstructive Pulmonary Disease.

Start date: January 31, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to test whether breathing control exercises embedded in occupational therapy sessions have an impact on quality of life and dyspnea in patients with chronic obstructive pulmonary disease (COPD).

NCT ID: NCT05196139 Completed - Clinical trials for Age-Related Macular Degeneration

Visual Outcome After Vitrectomy With Subretinal tPA Injection

EVA-tPA
Start date: April 1, 2021
Phase:
Study type: Observational

evaluate the safety of Eva surgical system

NCT ID: NCT05195957 Completed - Clinical trials for Abdominal Wall Hernia

Outcomes of Open Versus Robotic-assisted Laparoscopic Posterior Component Separation in Complex Abdominal Wall Repair

EUROTAR
Start date: January 17, 2021
Phase:
Study type: Observational [Patient Registry]

This is a retrospective European multicenter study evaluating surgical treatment of patients with a complex ventral incisional hernia using robotic-assisted laparoscopic transversus abdominis release (rTAR) or open transversus abdominis release (oTAR).